388 related articles for article (PubMed ID: 29779544)
1. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
Andrilla CHA; Coulthard C; Patterson DG
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
[TBL] [Abstract][Full Text] [Related]
2. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
Andrilla CHA; Coulthard C; Larson EH
Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
[TBL] [Abstract][Full Text] [Related]
3. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
Andrilla CHA; Moore TE; Patterson DG
J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
5. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.
Haffajee RL; Bohnert ASB; Lagisetty PA
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S230-S242. PubMed ID: 29779547
[TBL] [Abstract][Full Text] [Related]
6. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
Andrilla CHA; Jones KC; Patterson DG
J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
[TBL] [Abstract][Full Text] [Related]
7. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
[TBL] [Abstract][Full Text] [Related]
8. Why aren't physicians prescribing more buprenorphine?
Huhn AS; Dunn KE
J Subst Abuse Treat; 2017 Jul; 78():1-7. PubMed ID: 28554597
[TBL] [Abstract][Full Text] [Related]
9. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
[TBL] [Abstract][Full Text] [Related]
10. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
Knudsen HK
J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
[TBL] [Abstract][Full Text] [Related]
11. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.
Ghertner R
Drug Alcohol Depend; 2019 Nov; 204():107527. PubMed ID: 31525570
[TBL] [Abstract][Full Text] [Related]
12. Prescribing patterns of buprenorphine waivered physicians.
Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
[TBL] [Abstract][Full Text] [Related]
13. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
Andrilla CHA; Moore TE; Patterson DG; Larson EH
J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
[TBL] [Abstract][Full Text] [Related]
14. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
Wen H; Hockenberry JM; Pollack HA
JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
16. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
Peterson LE; Morgan ZJ; Borders TF
J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians.
Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H;
JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
Rhee TG; Rosenheck RA
Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.
Jones CM; Diallo MM; Vythilingam M; Schier JG; Eisenstat M; Compton WM
Drug Alcohol Depend; 2021 Aug; 225():108783. PubMed ID: 34049102
[TBL] [Abstract][Full Text] [Related]
20. Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis.
Knudsen HK; Lin LA; Lofwall MR
Subst Abus; 2020; 41(2):259-268. PubMed ID: 31295057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
